ACTH, beta-endorphin, substance P, and corticotrophin releasing hormone in plasma and follicular fluid in hormonally stimulated menstrual cycles for in-vitro fertilization in the human.

Author： Kerdelhué B   Lenoir V   Kolm P   Seltman H J   Jones H W   Jones G S  

Publisher： Oxford University Press

ISSN： 1460-2350

Source： Human Reproduction, Vol.12, Iss.2, 1997-02, pp. : 231-235

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Developmental potential of embryos produced by in-vitro fertilization from gonadotrophin-releasing hormone antagonist-treated macaques stimulated with recombinant human follicle stimulating hormone alone or in combination with luteinizing hormone

By Weston A.M.  

Human Reproduction, Vol. 11, Iss. 3, 1996-03 ,pp. : 608-613

Oxford University Press

Access to resources Recommend Favorite

The relationship between follicular fluid aspirate volume and oocyte maturity in in-vitro fertilization cycles

By Salha O   Nugent D   Dada T   Kaufmann S   Levett S   Jenner I   Lui S   Sharma V  

Human Reproduction, Vol. 13, Iss. 7, 1998-07 ,pp. : 1901-1906

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze–thaw cycles

By Kol S.  

Human Reproduction, Vol. 14, Iss. 9, 1999-09 ,pp. : 2242-2244

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. Luteal phase and clinical outcome after human menopausal gonadotrophin/gonadotrophin releasing hormone antagonist treatment for ovarian stimulation in in-vitro fertilization/intracytoplasmic sperm injection cycles

By Albano C.  

Human Reproduction, Vol. 14, Iss. 6, 1999-06 ,pp. : 1426-1430

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. Follicular and luteal phase characteristics following early cessation of gonadotrophin-releasing hormone agonist during ovarian stimulation for in-vitro fertilization

By Beckers N.G.M.  

Human Reproduction, Vol. 15, Iss. 1, 2000-01 ,pp. : 43-49

Oxford University Press

Access to resources Recommend Favorite